Honda Civic Recall Issued Over Parking Brake Problems, Rollaway Accident Risk

More than 350,000 Honda Civic vehicles are being recalled due to a risk the electronic parking brake may fail, potentially allowing vehicles to roll away when turned off and cause an accident or crash. 

The Honda Civic parking brake recall was announced by the U.S. National Highway Traffic Safety Administration (NHTSA) on October 13, after reviewing at least 342 warranty claims that indicated the electronic parking brake (EPB) may not engage if it is applied immediately after turning the ignition off.

Although no injuries or crashes have been reported, the vehicles are being recalled due to the potential roll-away and crash hazards they pose if the parking brake fails to engage. Children or passengers could be at an increased risk of a roll-away crash if the driver exits the vehicle without the parking brake engaging properly.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to the NHTSA, the EPB feature could be interfered with by the software programming of the Vehicle Stability Assist Electronic Control Unit (VSA ECU), by preventing the application of the EPB when the brake is applied immediately after the vehicle ignition is turned off.

Vehicle operators will be notified of when an parking brake failure is occurring by the illumination of a red brake light signal of the dashboard display. The brake light signal will blink red for 15 seconds following the parking brake’s failure.

Honda first started receiving warranty claims of the issue in December 2015, and opened an investigation in conjunction with its EPB parts supplier Continental. Honda received 342 customer complaints, and after testing to try and recreate the problem, decided a motor vehicle safety defect exists and that a recall was necessary.

The vehicles included in the recall are certain model year 2016 Honda Civic two door and four door vehicles with 1.5L turbo and 2.0L engines. An estimated 350,083 vehicles manufactured by American Honda Motor Company are included in the recall and have varying date ranges of production that can be found on the NHTSA recall notice.

Honda announced it will begin notifying owners of the defect and instruct customers to schedule an inspection at their local licensed Honda dealer for the vehicle’s software to be updated, free of charge. The recall is expected to begin on November 8, 2016. Customers with questions or further concerns regarding the recall may contact Honda customer service at 1-888-424-9153 and reference the recall number ‘KC6”.

1 Comments

  • GusDecember 1, 2016 at 3:48 am

    I've had my 2007 honda civic si for 4 years now and just two days ago my handbrake plastic realease button broke causing my car to roll down the drive was and hit a car. Notice the handbrake realease part was mainly plastic and may cause further problems for other civic owners

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.